TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? October 7, 2005
TCL Archive Grants & Contracts: NCI Workshop Informs Historically Black Institutions About Funding Process October 10, 1997
TCL Archive In Brief: Interim Bill Keeps NCI Going Through Oct. 31; “Manual Fr Staging Of Cancer” Now Available October 21, 1977
TCL Archive In Brief: New York Legislature Votes $240 Mil. Bond Issue For Roswell Park Construction; Kripke Honored April 25, 1992
